Pharmaceutical design and build expert ZETA has opened a new subsidiary in Kazakhstan.
This new subsidiary will be called ZETA Solutions.
This expansion is part of ZETA's continuing global expansion that has included a subsidiary in Singapore in 2022, an Indian pharmaceutical construction expert acquisition in 2022, as well as an HVAC growth acquisition in Austria in 2021.
Plans for Kazakhstan
The goal of this most recent expansion is to support the local market with innovative solutions and at the same time strengthen the biotech and pharmaceutical industry in the CIS region.
The Commonwealth of Independent States (CIS) is a regional intergovernmental organisation in Eurasia.
ZETA Solutions, being part of the ZETA Group, offers the pharmaceutical and biotech industry customised services and solutions in the field of facility engineering and process equipment (upstream & downstream) for Kazakhstan and the CIS region.
This new subsidiary will be called ZETA Solutions
The subsidiary will draw on the expertise of the wider company to become a reliable general planner (EPCMv) for the implementation of large-scale pharmaceutical projects.
Services such as design qualifications, conducting GMP reviews for existing production facilities, process simulation, and other technical services will be provided.
“We are proud to strengthen our presence in the region,” said Christian Gabriel, Regional Manager CIS of ZETA Solutions. “Kazakhstan is considered a strategic location for the pharmaceutical and biotech industry due to its favourable geographical location and the government's support in promoting innovation and technology."